Updated:
STERIS Corporation
STERIS Corporation provides infection prevention products and sterilization services to hospitals, surgery centers, and life science manufacturers worldwide.
STERIS Corporation
STERIS is a leading provider of infection prevention and other procedural products and services. Learn more here.
General information
Firm type
Corporation
Year founded
1985
Location
Region
North America
Country
United States
City
Mentor
Corporate office
Mentor, OH, United States
Sector focus
Frequently asked questions
Who runs investment decisions at STERIS?
STERIS is a publicly traded company with a board of directors and executive leadership. The CEO and CFO lead capital allocation decisions, including acquisitions and internal investments. Specific principals are not named in the available public sources, though investor relations materials list contact information for shareholder inquiries.
How does STERIS source products and innovations?
STERIS develops internal products and also acquires companies with established product lines and operating histories. Its website cites historical acquisitions, including American Sterilizer Company, which augment its sterilization and surgical equipment offerings. The company does not disclose a separate venture arm or proprietary deal-flow network.
What investment stages does STERIS typically target?
STERIS does not target investment stages as a venture firm or private equity fund. It operates as a manufacturer and service provider of infection prevention products. Its acquisitions have historically focused on mature businesses with complementary product lines or service capabilities. No direct early-stage or growth-equity investments are disclosed.
Which sectors does STERIS serve?
STERIS serves the healthcare sector, specifically hospitals and surgery centers (infection prevention, sterilization, endoscopy, surgical tools) and the life science industry (biotechnology, pharmaceutical, and medical device manufacturers). It also serves research laboratories. The company explicitly avoids consumer-facing wellness products and unrelated industrial verticals, focusing on regulated medical and scientific environments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: